Cargando…
Uptake and 1-year outcomes of lung transplantation for COVID-19
OBJECTIVE: End-stage lung disease from severe COVID-19 infection is an increasingly common indication for lung transplantation (LT), but there are limited data on outcomes. We evaluated 1-year COVID-19 LT outcomes. METHODS: We identified all adult US LT recipients January 2020 to October 2022 in the...
Autores principales: | Ruck, Jessica M., Zhou, Alice L., Florissi, Isabella, Ha, Jinny S., Shah, Pali D., Massie, Allan B., Segev, Dorry L., Merlo, Christian A., Bush, Errol L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by The American Association for Thoracic Surgery
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240904/ https://www.ncbi.nlm.nih.gov/pubmed/37286074 http://dx.doi.org/10.1016/j.jtcvs.2023.05.029 |
Ejemplares similares
-
Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients
por: Ruck, Jessica M., et al.
Publicado: (2022) -
Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021) -
Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022) -
Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023) -
Lung Transplantation in Patients With COVID-19-The Early National Experience
por: Florissi, Isabella S., et al.
Publicado: (2022)